EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives

Magdalena Rados iD, Anna Landegger, Lukas Schmutzler, Kimberlie Rabidou, Sabine Taschner-Mandl iD, Irfete S Fetahu iD

Cancer and Metastasis Reviews · 2024-12 · 43 (4) · 1401-1417

DOI: 10.1007/s10555-024-10212-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, online erschienen am 18.09.2024. Verfasst von Magdalena Rados und 5 weiteren Autor:innen. Beteiligte Einrichtung: St. Anna Children's Cancer Research Institute, Vienna, Austria. Hauptthemen laut MEDLINE: Neuroblastoma, Killer Cells, Natural, Immunotherapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells have multifaceted roles within the complex tumor milieu. They are pivotal components of innate immunity and shape the dynamic landscape of tumor-immune cell interactions, and thus can be leveraged for use in therapeutic interventions. NK-based immunotherapies have had remarkable success in hematological malignancies, but these therapies are met with many challenges in solid tumors, including neuroblastoma (NB), a childhood tumor arising from the sympathetic nervous system. With a focus on NB, this review outlines the mechanisms employed by NK cells to recognize and eliminate malignant cells, delving into the dynamic relationship between ligand-receptor interactions, cytokines, and other molecules that facilitate the cross talk between NK and NB cells. We discuss the immunomodulatory functions of NK cells and the mechanisms that contribute to loss of this immunosurveillance in NB, with a focus on how this dynamic has been utilized in recent immunotherapy advancements for NB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaKiller Cells, NaturalImmunotherapyHumansAnimals

Stichwörter der Autor:innen

Adoptive NK cellular therapyAnti-GD2 antibodyCAR-NK cellsImmunotherapyNK cellsNeuroblastoma

Autor:innen und Institutionen

  • St. Anna Children's Cancer Research Institute, Vienna, Austria.
  • Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Otorhinolaryngology - Head and Neck Surgery, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Department of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria. irfete.fetahu@meduniwien.ac.at.
  • Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. irfete.fetahu@meduniwien.ac.at.

ORCID-Profile: Magdalena Rados, Sabine Taschner-Mandl, Irfete S Fetahu

Förderung

  • Medical University of Vienna

Zitieren

APA

Rados, M., Landegger, A., Schmutzler, L., Rabidou, K., Taschner-Mandl, S., & Fetahu, I. S. (2024). Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives. Cancer and Metastasis Reviews, 43(4), 1401-1417. https://doi.org/10.1007/s10555-024-10212-8

Vancouver

Rados M, Landegger A, Schmutzler L, Rabidou K, Taschner-Mandl S, Fetahu IS. Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives. Cancer and Metastasis Reviews. 2024;43(4):1401-1417. doi:10.1007/s10555-024-10212-8

BibTeX
@article{Rados2024,
  author = {Rados, Magdalena and Landegger, Anna and Schmutzler, Lukas and Rabidou, Kimberlie and Taschner-Mandl, Sabine and Fetahu, Irfete S},
  title = {Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives},
  journal = {Cancer and Metastasis Reviews},
  year = {2024},
  volume = {43},
  number = {4},
  pages = {1401--1417},
  doi = {10.1007/s10555-024-10212-8}
}
Kostenlos starten →